RDVT vs SRPT · P/E 78, rev $75.2M vs rev $1.90B
Red Violet Inc (RDVT) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Red Violet Inc (RDVT) is a software - application company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported RDVT revenue for 2024-12-31 was $75.2M. Net income was $7.0M. Revenue was up 24.9% from 2023-12-31 to 2024-12-31. RDVT currently screens at market cap $663.2M and trailing P/E 77.9.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
RDVT currently screens at market cap $663.2M and trailing P/E 77.9. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the RDVT and SRPT stock pages for the full models.
Not investment advice.